CD19 and neoplasm: Notably, these NK cells carry, non-NK, tumor cell antigens on their surface, evidence of trogocytosis during tumor cell killing, i.e., they carry CD19 in B cell-derived cancers and CD14 in myeloid-derived cancers (21, 23, 24).